Industry News
Research, Science & Manufacturer Updates
Therapeutics Articles
Grifols has made a major equity investment in Alkahest to work together to develop novel plasma-based products for the treatment of cognitive decline in aging and disorders of the central nervous system.
A recent study shows that a vaccine typically used to prevent tuberculosis in countries outside of the U.S. could also prevent multiple sclerosis (MS) in people who are in the beginning stages of the disease.
Researchers at King’s College London have identified a new gene, PIM1, which could be an effective target for innovative treatments and therapies for psoriasis, an autoimmune disease.
A recent study of an experimental therapy that alters cancer patients’ own immune cells to recognize an often deadly form of leukemia has shrunk tumors and sent the cancer into remission in adults.